Cefpodoxime Proxetil Granule, For Suspension
Product Images NDC 65862-140

5 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefpodoxime Proxetil (NDC 65862-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL (100 mL Bottle))

Package Label-principal Display Panel (100 mg/5 mL (100 mL Bottle))
Label for Cefpodoxime Proxetil for Oral Suspension, USP 50 mg/5 mL granules for suspension, 100 mL when constituted, distributed by Aurobindo Pharma USA, Inc. The label includes dosage strength, storage instructions, mixing directions, and warnings.*
FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL Carton Label)

Package Label-principal Display Panel (100 mg/5 mL Carton Label)
Packaging label for Cefpodoxime Proxetil 50 mg/5 mL oral granule suspension by Aurobindo Pharma Limited. The label includes instructions for mixing and storage, noting it is a 100 mL bottle when constituted. It features branding, barcode, and distribution information from Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (50 mg/5 mL (100 mL Bottle))

Package Label-principal Display Panel (50 mg/5 mL (100 mL Bottle))
Cefpodoxime Proxetil for Oral Suspension, USP 100 mg/5 mL granules label by Aurobindo Pharma Limited. The 100 mL label includes dosage strength, storage instructions, usage directions for reconstitution and mixing, warnings, and distributor information for Aurobindo Pharma USA, Inc. This Rx-only oral suspension is made in India.*
FDA Label Image

Package Label-principal Display Panel (50 mg/5 mL Carton Label)

Package Label-principal Display Panel (50 mg/5 mL Carton Label)
Packaging label for Cefpodoxime Proxetil oral granules for suspension, USP 100 mg/5 mL from Aurobindo Pharma Limited. The label includes preparation instructions, storage conditions, and warnings. The package contains 100 mL when constituted and is marked Rx only. Distributed by Aurobindo Pharma USA, Inc. with relevant barcode and NDC 65862-141-01.*
FDA Label Image

Chemical Structure (Cefpodoxime Str)

Chemical Structure (Cefpodoxime Str)
Chemical structure of Cefpodoxime Proxetil, the active ingredient in the granule for suspension oral dosage form by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.